RxDoctor Payments Data

Sampath Gunda, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1477865301

Payments from drug & device makers

What this record shows

This record is dominated by grants: $56,888 of the $72,916 with a category attached, or 78.0%. 17 manufacturers reported payments, led by Medtronic at 59.8% of the total. Reporting peaked in 2020 at $45,113 and has fallen 99.0% since, to $442 in 2025.

$72,916in general payments, 2019–2025

Across 164 payments — averaging $444.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$44K
  • Boston Scientific$20K
  • Abbott$5K
  • Biotronik Inc.$3K
  • Biosense Webster, Inc.$383
  • Johnson & Johnson$155
  • plus $755 from 11 others

What the payments were for

  • Grants$56,88878%
  • Travel & lodging$9,53613%
  • Food & beverage$6,4799%
  • Education$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,916 in reported general payments places this provider in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$116,176
Medicare patients
1,323
Services billed
1,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$145,446
XareltoRivaroxaban24$32,530
Dofetilide36$4,285
Flecainide Acetate19$792
Metoprolol Succinate59$704
Amiodarone Hcl42$624
Atorvastatin Calcium16$316
Metoprolol Tartrate26$102
Carvedilol11$100
Lisinopril12$72
Losartan Potassium11$69
Amlodipine Besylate11$32

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$84$145,446125 claims
Johnson & JohnsonXarelto$155$32,53024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

Other clinical cardiac electrophysiology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →